Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HUMAN VACCINE ADJUVANTS INDUSTRY
2.1 Summary about Human Vaccine Adjuvants Industry
2.2 Human Vaccine Adjuvants Market Trends
2.2.1 Human Vaccine Adjuvants Production & Consumption Trends
2.2.2 Human Vaccine Adjuvants Demand Structure Trends
2.3 Human Vaccine Adjuvants Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oral
4.2.2 Subcutaneous
4.2.3 Intramuscular
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Research Applications
4.3.2 Commercial Applications
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oral
5.2.2 Subcutaneous
5.2.3 Intramuscular
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Research Applications
5.3.2 Commercial Applications
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oral
6.2.2 Subcutaneous
6.2.3 Intramuscular
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Research Applications
6.3.2 Commercial Applications
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oral
7.2.2 Subcutaneous
7.2.3 Intramuscular
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Research Applications
7.3.2 Commercial Applications
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oral
8.2.2 Subcutaneous
8.2.3 Intramuscular
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Research Applications
8.3.2 Commercial Applications
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oral
9.2.2 Subcutaneous
9.2.3 Intramuscular
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Research Applications
9.3.2 Commercial Applications
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 CSL Limited
10.1.3 Brenntag Biosector
10.1.4 SEPPIC
10.1.5 SPI Pharma
10.1.6 Novavax
10.1.7 Avanti Polar Lipids
10.1.8 Aphios
10.2 Human Vaccine Adjuvants Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 CSL Limited
10.2.3 Brenntag Biosector
10.2.4 SEPPIC
10.2.5 SPI Pharma
10.2.6 Novavax
10.2.7 Avanti Polar Lipids
10.2.8 Aphios
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Human Vaccine Adjuvants Product Type Overview
Table Human Vaccine Adjuvants Product Type Market Share List
Table Human Vaccine Adjuvants Product Type of Major Players
Table Brief Introduction of GSK
Table Brief Introduction of CSL Limited
Table Brief Introduction of Brenntag Biosector
Table Brief Introduction of SEPPIC
Table Brief Introduction of SPI Pharma
Table Brief Introduction of Novavax
Table Brief Introduction of Avanti Polar Lipids
Table Brief Introduction of Aphios
Table Products & Services of GSK
Table Products & Services of CSL Limited
Table Products & Services of Brenntag Biosector
Table Products & Services of SEPPIC
Table Products & Services of SPI Pharma
Table Products & Services of Novavax
Table Products & Services of Avanti Polar Lipids
Table Products & Services of Aphios
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Human Vaccine Adjuvants Market Forecast (Million USD) by Region 2021f-2026f
Table Global Human Vaccine Adjuvants Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Human Vaccine Adjuvants Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Human Vaccine Adjuvants Market Forecast (Million USD) Share by Demand 2021f-2026f